• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胰高血糖素样肽-1受体激动剂对内镜检查结果的影响:系统评价和荟萃分析。

Effects of glucagon-like peptide-1 receptor agonists on endoscopy outcomes: systematic review and meta-analysis.

作者信息

Singh Sahib, Rahman Syed Hamaad, Khan Nihal, Rajagopal Anjali, Shafique Nouman, Tawde Poonam, Bhardwaj Vaishali, Suresh Kumar Vishnu Charan, Aswath Ganesh, Inamdar Sumant, Dutta Sudhir, Hurairah Abu, Mohan Babu P

机构信息

Department of Internal Medicine, Sinai Hospital of Baltimore, Baltimore, Maryland, USA.

Department of Internal Medicine, Methodist Dallas Medical Center, Dallas, Texas, USA.

出版信息

Gastrointest Endosc. 2025 Feb;101(2):343-349.e5. doi: 10.1016/j.gie.2024.10.011. Epub 2024 Oct 12.

DOI:10.1016/j.gie.2024.10.011
PMID:39401599
Abstract

BACKGROUND AND AIMS

Glucagon-like peptide-1 receptor agonists (GLP-1RAs) are known to cause delayed gastric emptying; however, the effect on clinical outcomes during upper endoscopy and colonoscopy remains unclear. We conducted a meta-analysis to reconcile the data.

METHODS

Online databases were searched for studies evaluating GLP-1RAs versus a control group (no GLP-1RAs) in patients undergoing endoscopy. The outcomes of interest were rate of retained gastric contents (RGCs), aborted procedures, aspiration events, and subjective bowel preparation quality. Pooled odds ratios (ORs) and 95% confidence intervals (CIs) were estimated using a random-effects model.

RESULTS

Twenty-three studies with 77,152 patients (4449 in the GLP-1RA arm and 72,703 in the control arm) were included. Mean patient age ranged from 47.6 to 72 years, and 58.4% were women. As compared with the control group, the GLP-1RA group had higher odds of RGCs (OR, 15.39; 95% CI, 4.65-50.99; P < .01) and aborted procedures (OR, 13.86; 95% CI, 4.42-43.43; P < .01). No significant differences were observed between the 2 groups in terms of aspiration events (OR, 21.06; 95% CI, .13-3379.01; P = .24) and subjective bowel preparation quality (OR, .94; 95% CI, .67-1.31; P = .83).

CONCLUSIONS

Although statistical significance was reached in terms of visible RGCs and early termination of endoscopies in patients on GLP-1RAs, these events were overall rare. GLP-1RAs do not appear to pose significant risk, as the odds of developing aspiration were comparable in the 2 groups.

摘要

背景与目的

已知胰高血糖素样肽-1受体激动剂(GLP-1RAs)会导致胃排空延迟;然而,其对上消化道内镜检查和结肠镜检查期间临床结局的影响仍不明确。我们进行了一项荟萃分析以整合数据。

方法

检索在线数据库,查找评估接受内镜检查患者中GLP-1RAs与对照组(未使用GLP-1RAs)的研究。感兴趣的结局包括胃内容物残留率(RGCs)、检查中止、误吸事件以及主观肠道准备质量。采用随机效应模型估计合并比值比(OR)和95%置信区间(CI)。

结果

纳入了23项研究,共77152例患者(GLP-1RA组4449例,对照组72703例)。患者平均年龄在47.6至72岁之间,58.4%为女性。与对照组相比,GLP-1RA组胃内容物残留的几率更高(OR,15.39;95%CI,4.65 - 50.99;P <.01),检查中止的几率也更高(OR,13.86;95%CI,4.42 - 43.43;P <.01)。两组在误吸事件(OR,21.06;95%CI,.13 - 3379.01;P =.24)和主观肠道准备质量方面未观察到显著差异(OR,.94;95%CI,.67 - 1.31;P =.83)。

结论

尽管使用GLP-1RAs的患者在可见胃内容物残留和内镜检查提前终止方面达到了统计学显著性,但这些事件总体上很少见。由于两组发生误吸的几率相当,GLP-1RAs似乎不会带来重大风险。

相似文献

1
Effects of glucagon-like peptide-1 receptor agonists on endoscopy outcomes: systematic review and meta-analysis.胰高血糖素样肽-1受体激动剂对内镜检查结果的影响:系统评价和荟萃分析。
Gastrointest Endosc. 2025 Feb;101(2):343-349.e5. doi: 10.1016/j.gie.2024.10.011. Epub 2024 Oct 12.
2
Glucagon-like peptide-1 receptor agonist use and the risk of residual gastric contents and aspiration in patients undergoing GI endoscopy: a systematic review and a meta-analysis.胰高血糖素样肽-1受体激动剂的使用与接受胃肠内镜检查患者的残余胃内容物及误吸风险:一项系统评价和荟萃分析
Gastrointest Endosc. 2025 Apr;101(4):762-771.e13. doi: 10.1016/j.gie.2024.12.019. Epub 2024 Dec 16.
3
Effects of Glucagon-Like Peptide-1 Receptor Agonists on Upper Gastrointestinal Endoscopy: A Meta-Analysis.胰高血糖素样肽-1受体激动剂对上消化道内镜检查的影响:一项荟萃分析。
Clin Gastroenterol Hepatol. 2025 Apr;23(5):715-725.e3. doi: 10.1016/j.cgh.2024.07.021. Epub 2024 Aug 12.
4
Glucagon-Like Peptide-1 Receptor Agonists Increase Solid Gastric Residue Rates on Upper Endoscopy Especially in Patients With Complicated Diabetes: A Case-Control Study.胰高血糖素样肽-1 受体激动剂在上消化道内镜检查中增加固体胃残留率,特别是在合并糖尿病患者中:一项病例对照研究。
Am J Gastroenterol. 2024 Jun 1;119(6):1081-1088. doi: 10.14309/ajg.0000000000002777. Epub 2024 Mar 27.
5
Perioperative glucagon-like peptide-1 receptor agonist use and retained gastric contents: A retrospective analysis of patients undergoing elective upper endoscopy.围手术期使用胰高血糖素样肽-1受体激动剂与胃内容物残留:一项对择期上消化道内镜检查患者的回顾性分析
J Clin Anesth. 2025 Mar;102:111776. doi: 10.1016/j.jclinane.2025.111776. Epub 2025 Feb 13.
6
Endoscopy and anesthesia outcomes associated with glucagon-like peptide-1 receptor agonist use in patients undergoing outpatient upper endoscopy.门诊上消化道内镜检查患者使用胰高血糖素样肽-1受体激动剂的内镜检查及麻醉效果
Gastrointest Endosc. 2025 Jan 15. doi: 10.1016/j.gie.2025.01.004.
7
Glucagon-like peptide-1 receptor agonists significantly affect the quality of bowel preparation for colonoscopy.胰高血糖素样肽-1受体激动剂对结肠镜检查肠道准备质量有显著影响。
Endoscopy. 2025 Feb;57(2):126-133. doi: 10.1055/a-2419-3875. Epub 2024 Oct 10.
8
Evidence Report on the Safety of Gastrointestinal Endoscopy in Patients on Glucagon-like Peptide-1 Receptor Agonists: A Systematic Review and Meta-Analysis.胰高血糖素样肽-1受体激动剂治疗患者胃肠道内镜检查安全性的证据报告:系统评价与荟萃分析
Diagnostics (Basel). 2025 Mar 19;15(6):770. doi: 10.3390/diagnostics15060770.
9
Glucagon-like peptide-1 receptor agonists and impaired gastric emptying: a pharmacovigilance analysis of the US Food and Drug Administration adverse event reporting system.胰高血糖素样肽-1受体激动剂与胃排空受损:美国食品药品监督管理局不良事件报告系统的药物警戒分析
Br J Anaesth. 2025 May;134(5):1486-1496. doi: 10.1016/j.bja.2024.10.013. Epub 2024 Nov 21.
10
Clinical Consequences of Delayed Gastric Emptying With GLP-1 Receptor Agonists and Tirzepatide.胰高血糖素样肽-1受体激动剂和替尔泊肽导致胃排空延迟的临床后果
J Clin Endocrinol Metab. 2024 Dec 18;110(1):1-15. doi: 10.1210/clinem/dgae719.

引用本文的文献

1
Aspiration Risk During Endoscopic Procedures While on GLP-1 Agonist Therapy.接受胰高血糖素样肽-1受体激动剂治疗时内镜检查过程中的误吸风险。
Dig Dis Sci. 2025 Aug 9. doi: 10.1007/s10620-025-09307-1.
2
Association between glucagon-like peptide-1 receptor agonist use and peri-operative pulmonary aspiration: a systematic review and meta-analysis.胰高血糖素样肽-1受体激动剂的使用与围手术期肺误吸之间的关联:一项系统评价和荟萃分析。
Anaesthesia. 2025 Jul;80(7):846-858. doi: 10.1111/anae.16601. Epub 2025 Apr 15.
3
Endoscopy and anesthesia outcomes associated with glucagon-like peptide-1 receptor agonist use in patients undergoing outpatient upper endoscopy.
门诊上消化道内镜检查患者使用胰高血糖素样肽-1受体激动剂的内镜检查及麻醉效果
Gastrointest Endosc. 2025 Jan 15. doi: 10.1016/j.gie.2025.01.004.